newsfilter
← Latest News
GlobeNewswire·

ARCA biopharma Announces 2021 Financial Results and Provides Corporate Update

WESTMINSTER, Colo., March 14, 2022 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (NASDAQ:ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today reported 2021